Literature DB >> 32800073

Characteristics and early outcomes of patients hospitalised for COVID-19 in North Zealand, Denmark.

Maria Elisabeth Lendorf1, Mogens Karsbøl Boisen, Peter Lommer Kristensen, Ellen Christine Leth Løkkegaard, Sebastian Moretto Krog, Lisbet Brandi, Louise Schouborg Brinth, Rúna Louise Mortansdóttir Nolsöe, Camilla Ryrsø, Pia Eiken, Morten Heiberg Bestle, Inger Merete Jørgensen, Ulrik Pedersen-Bjergaard, Birgitte Lindegaard, Thomas Broe Christensen, Thea Kølsen Fischer.   

Abstract

INTRODUCTION: Coronavirus disease 2019 (COVID-19) is an ongoing pandemic associated with significant morbidity and mortality worldwide. Limited data are available describing the clinical presentation and outcomes of hospitalised COVID-19 patients in Europe.
METHODS: This was a single-centre retrospective chart review of all patients with COVID-19 admitted to the North Zealand Hospital in Denmark between 1 March and 4 May 2020. Main outcomes include major therapeutic interventions during hospitalisation, such as invasive mechanical ventilation, as well as death.
RESULTS: A total of 115 patients were included, including four infants. The median age of adults was 68 years and 40% were female. At admission, 55 (50%) patients had a fever, 29 (26%) had a respiratory rate exceeding 24 breaths/minute, and 78 (70%) received supplemental oxygen. The prevalence of co-infection was 13%. Twenty patients (18%) (median age: 64 years; 15% female) were treated in the intensive care unit. Twelve (10.4%) received invasive mechanical ventilation and three (2.6%) renal replacement therapy. Nine patients (8%) developed pulmonary embolism. Sixteen patients (14%) died. Among patients requiring mechanical ventilation (n = 12), seven (6.1%) were discharged alive, four (3.4%) died and one (0.9%) was still hospitalised.
CONCLUSION: In this cohort of hospitalised COVID-19 patients, mortality was lower than in other Danish and European case series. FUNDING: none. TRIAL REGISTRATION: not relevant. Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Entities:  

Mesh:

Year:  2020        PMID: 32800073

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  5 in total

1.  Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.

Authors:  Jackson S Musuuza; Lauren Watson; Vishala Parmasad; Nathan Putman-Buehler; Leslie Christensen; Nasia Safdar
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

2.  Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis.

Authors:  Li Shi; Jie Xu; Wenwei Xiao; Ying Wang; Yuefei Jin; Shuaiyin Chen; Guangcai Duan; Haiyan Yang; Yadong Wang
Journal:  Ann Allergy Asthma Immunol       Date:  2021-02-18       Impact factor: 6.347

Review 3.  Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis.

Authors:  Zeinab Abdelrahman; Qian Liu; Shanmei Jiang; Mengyuan Li; Qingrong Sun; Yue Zhang; Xiaosheng Wang
Journal:  Front Pharmacol       Date:  2021-03-15       Impact factor: 5.810

4.  Coronary heart disease and COVID-19: A meta-analysis.

Authors:  Chendi Liang; Weijun Zhang; Shuzhen Li; Gang Qin
Journal:  Med Clin (Engl Ed)       Date:  2021-06-05

5.  Pulmonary Embolism Does Not Have an Unusually High Incidence Among Hospitalized COVID19 Patients.

Authors:  Nicolas Gallastegui; Jenny Y Zhou; Annette von Drygalski; Richard F W Barnes; Timothy M Fernandes; Timothy A Morris
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.